Showing results (1081-1090 of 1,499) with videos related to

Sort By:
Pageof 150
Circulation|October 26, 2006
BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shuntsMichael J Mullen, David Hildick-Smith, Joseph V De Giovanni, et al.
Psychiatry Research|August 1, 1988
Social functioning in chronic depression: effect of 6 weeks of antidepressant treatmentJ W Stewart, F M Quitkin, P J McGrath, et al.
Medical Engineering & Physics|February 20, 2025
Mathematical representation and nonlinear modelling of the Wheatley mitral valveH L Oliveira, G C Buscaglia, J A Cuminato, et al.
The Journal of Clinical Psychiatry|June 26, 2003
"Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?Stephen J Donovan, Edward V Nunes, Jonathan W Stewart, et al.
Pharmacotherapy|November 12, 2021
A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non-obese controlsAaron W Stewart, Alexandra Shillingburg, William Petros, et al.
Journal of Traumatic Stress|July 23, 2021
A Pilot Trial of Universal School-Based Mental Health Screening in El Salvador: Traumatic Stress in an Underresourced School EnvironmentRegan W Stewart, Bianca T Villalobos, Aubrey R Dueweke, et al.
Retina (Philadelphia, Pa.)|May 10, 2022
SAFETY AND THERAPEUTIC EFFECTS OF ORALLY ADMINISTERED AKST4290 IN NEWLY DIAGNOSED NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONMichael W Stewart, Seema Garg, Erin M Newman, et al.
Diabetes Care|July 1, 1995
Features of syndrome X in first-degree relatives of NIDDM patientsM W Stewart, D B Humphriss, T S Berrish, et al.
British Journal of Haematology|May 1, 1996
Thrombo-embolic disease after splenectomy for hereditary stomatocytosisG W Stewart, J A Amess, S W Eber, et al.
Diabetologia|November 19, 2015
Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exerciseMichael A Nauck, Murray W Stewart, Christopher Perkins, et al.
Pageof 150